TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18996875

Group type: EXPERIMENTAL
Intervention: Dual-fortified salt with iron as micronized ground ferric pyrophosphate (MGFePP) at 2 mg/g salt
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Dual-fortified salt with iron as encapsulated ferrous fumarate (EFF) at 2 mg/g salt
Number of subjects: 458

Group type: COMPARATOR
Intervention: Iodized salt (IS)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Dual-fortified salt with iron as micronized ground ferric pyrophosphate (MGFePP)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Dual-fortified salt with iron as encapsulated ferrous fumarate (EFF)
Number of subjects: 458
Study: 16001284

Group type: EXPERIMENTAL
Intervention: T1-weighted MRI for whole-body adipose tissue quantification
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Volume selective MRS for IHCL and IMCL determination
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Correlation analysis
Number of subjects: 150
Study: 14586384

Group type: EXPERIMENTAL
Intervention: Cooperstown cocktail
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cooperstown 5+1 cocktail
Number of subjects: 12
Study: 11387359

Group type: EXPERIMENTAL
Intervention: epoetin alfa 150 to 300 IU/kg
Number of subjects: 375

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 375
Study: 9195022

Group type: EXPERIMENTAL
Intervention: Clinic-based rehabilitation (three visits per week for 6 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Home-based physical therapy (number of visits determined by patient response)
Number of subjects: 37
Study: 1582794

Group type: EXPERIMENTAL
Intervention: Ophthalmoscopy (indirect and direct) by a retina specialist
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Seven standard field fundus photographs read by the same retina specialist
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Trained photographic grader at the Fundus Photograph Reading Center
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Ophthalmoscopy
Number of subjects: 124
Study: 3011440

Group type: EXPERIMENTAL
Intervention: Perindopril (8 mg orally)
Number of subjects: 10
Study: 31951599

Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids (O-PUFA) for 8 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Olive oil (control) for 8 weeks
Number of subjects: 73
Study: 29742942

Group type: EXPERIMENTAL
Intervention: Low dose vaginal misoprostol
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combined low dose vaginal misoprostol plus Foley catheter
Number of subjects: 78
Study: 29240860

Group type: EXPERIMENTAL
Intervention: ixekizumab 80 mg injection every 2 weeks after a 160 mg starting dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: etanercept 50 mg twice weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 26348584

Group type: EXPERIMENTAL
Intervention: Low-dose aripiprazole added to antidepressant therapy
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Pooled response rates across phases and treatments
Number of subjects: 225
Study: 23557594

Group type: EXPERIMENTAL
Intervention: Rotigotine transdermal system (2-16 mg/24 h)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 21812544

Group type: EXPERIMENTAL
Intervention: Child-on-child vignette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adult-on-child vignette
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Female participants
Number of subjects: 0
Study: 18786961

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 30 microg adrenaline
Number of subjects: 270

Group type: COMPARATOR
Intervention: Saline injection (0.30 ml)
Number of subjects: 270
Study: 16671841

Group type: EXPERIMENTAL
Intervention: Swedish Communication Screening at 18 months (SCS18)
Number of subjects: 2080

Group type: COMPARATOR
Intervention: Traditional method of identification (informal assessment)
Number of subjects: 2080
Study: 15638029

Group type: EXPERIMENTAL
Intervention: Aside-bending and up-standing method
Number of subjects: 261

Group type: COMPARATOR
Intervention: Traditional massage method
Number of subjects: 261
Study: 11159240

Group type: EXPERIMENTAL
Intervention: 75 mg hyperbaric lidocaine 5% (n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 12 mg hyperbaric bupivacaine 0.75% (n = 100)
Number of subjects: 200
Study: 9628552

Group type: EXPERIMENTAL
Intervention: Caffeine intake 300 to 700 mg/d
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Caffeine intake >700 mg/d
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Caffeine intake >300 mg/d from coffee (smoking women)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Nonsmoking women with caffeine intake <300 mg/d
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Smoking women
Number of subjects: 430
Study: 8143437

Group type: EXPERIMENTAL
Intervention: Glass-ionomer sealants (Fuji III)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Resin-based sealants (Delton)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Both groups (glass-ionomer and resin-based)
Number of subjects: 166
Study: 3060967

Group type: EXPERIMENTAL
Intervention: Cefotetan 2 g administered during induction of anesthesia
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 71
Study: 2007795

Group type: EXPERIMENTAL
Intervention: Auricular TENS
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo (no stimulation)
Number of subjects: 3
Study: 1095262

Group type: EXPERIMENTAL
Intervention: Mefruside
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cyclopenthiazide
Number of subjects: 30
Study: 31306889

Group type: EXPERIMENTAL
Intervention: Strong patient-surgeon relationship characterized by informational and emotional support
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Individualized disease- and treatment-related information
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Adequate time for asking questions with thoughtful answers tailored to their case
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Emotional support from the surgeon characterized by empathy and validation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Surgeons acknowledging patients as unique individuals
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Suboptimal support from surgeons
Number of subjects: 32
Study: 28835090

Group type: EXPERIMENTAL
Intervention: p16/Ki‐67 dual staining
Number of subjects: 980

Group type: COMPARATOR
Intervention: Thinprep cytologic test (TCT)
Number of subjects: 980
Study: 26003018

Group type: EXPERIMENTAL
Intervention: Distal protection filter during PCI
Number of subjects: 85

Group type: COMPARATOR
Intervention: No distal protection filter during PCI
Number of subjects: 85
Study: 23929930

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (77 ± 9 mmol/d)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal-sodium diet (144 ± 7 mmol/d)
Number of subjects: 11
Study: 21641348

Group type: EXPERIMENTAL
Intervention: Resting technetium-99m tetrofosmin-gated single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Nuclear variables added to clinical information
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: LV phase SD
Number of subjects: 240
Study: 19367181

Group type: EXPERIMENTAL
Intervention: Minimal enteral feeding (MEF) initiated 5 days after bowel reintegration, increased by 12 mL/kg/day
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group with delayed enteral nutrition until resolution of postoperative ileus
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Minimal enteral feeding (MEF)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Nutritional protocol
Number of subjects: 73
Study: 16707406

Group type: EXPERIMENTAL
Intervention: Positive control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manual measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Automated measurement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15551720

Group type: EXPERIMENTAL
Intervention: Azelaic acid 15% gel
Number of subjects: 40
Study: 14728005

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (loading dose of 300 mg followed by 75 mg daily)
Number of subjects: 12562

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 12562

Group type: EXPERIMENTAL
Intervention: Clopidogrel in patients undergoing PCI
Number of subjects: 12562

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 12562
Study: 9517604

Group type: EXPERIMENTAL
Intervention: Intensive smoking cessation program with inhaled bronchodilator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive smoking cessation program with placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 8000984

Group type: EXPERIMENTAL
Intervention: Low-dose mitoxantrone (MX)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 3149291

Group type: EXPERIMENTAL
Intervention: atenolol, 50-100 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: trichloromethiazide, 2-4 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: slow release nifedipine, 40-80 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: captopril, 37.5-75 mg
Number of subjects: 156

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 156
Study: 31583699

Group type: EXPERIMENTAL
Intervention: Melatonin 2 mg
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Melatonin 4 mg
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Melatonin 8 mg
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: COMPARATOR
Intervention: Comparison of placebo to any dose of melatonin
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 69
Study: 29076530

Group type: EXPERIMENTAL
Intervention: Integrative exercise (IE)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 47
Study: 26921116

Group type: EXPERIMENTAL
Intervention: Individualized metacognitive therapy program (MCT+)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Cognitive remediation (MyBrainTraining©)
Number of subjects: 328
Study: 25657309

Group type: EXPERIMENTAL
Intervention: MetS without T2D
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: MetS with T2D
Number of subjects: 78

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 78
Study: 23609363

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Bisoprolol (double-vessel and multi-vessel sub-groups)
Number of subjects: 222
Study: 21962194

Group type: EXPERIMENTAL
Intervention: Homeopathic Sulphur (6c, 12c, 30c potency)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Homeopathic Pulsatilla (6c, 12c, 30c potency)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Solvent controls (plain distilled water and water-ethanol (95%) solution)
Number of subjects: 100
Study: 18923232

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiangiotensin vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-obesity vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccine targeting heat shock proteins and oxidized low-density lipoprotein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccine to inhibit cholesteryl ester transfer protein
Number of subjects: 0
Study: 17041286

Group type: EXPERIMENTAL
Intervention: Adherence to antipsychotic medication
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Mediating variables (symptomatic impairment, global functioning, medication side effects)
Number of subjects: 409
Study: 12456382

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fluticasone/salmeterol (FP/SM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fluticasone (FP)
Number of subjects: 22
Study: 11465301

Group type: EXPERIMENTAL
Intervention: Nasal calcitonin (Miacalcin®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etidronate
Number of subjects: 0
Study: 9542560

Group type: EXPERIMENTAL
Intervention: Deltoid injection of scopolamine 6 micrograms/kg plus morphine 200 micrograms/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Gluteal injection of scopolamine 6 micrograms/kg plus morphine 200 micrograms/kg
Number of subjects: 12
Study: 8168033

Group type: EXPERIMENTAL
Intervention: Acylaminopenicillin plus aminoglycoside (Group A)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Third‐generation cephalosporin plus aminoglycoside (Group B)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Double beta‐lactam combination (Group C)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy without additional antifungal therapy
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Empirical amphotericin B plus 5‐fluorocytosine (given to nonresponders)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Addition of rifampin
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Fungi in microbiologically documented infections
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Leukocyte counts under study
Number of subjects: 295
Study: 2462402

Group type: EXPERIMENTAL
Intervention: Alfuzosin (7.5 mg or 10 mg/day)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Alfuzosin
Number of subjects: 417
Study: 30325791

Group type: EXPERIMENTAL
Intervention: Eccentric phase duration of 2 seconds (C2/E2)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Eccentric phase duration of 4 seconds (C2/E4)
Number of subjects: 22
Study: 30049238

Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate (17-OHPC)
Number of subjects: 356
Study: 30276916

Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Circuit Training (HIFCT), n=20, 3 times/week for 6 weeks, 15-minute workouts with 20s all-out bouts and 10s breaks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Moderate Aerobic Exercise (MAE), n=13, 3 times/week for 6 weeks, 50 minutes at moderate intensity
Number of subjects: 33
Study: 29851640

Group type: EXPERIMENTAL
Intervention: Prototype houses (bamboo, shade net, timber)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Modified reference houses
Number of subjects: 6

Group type: COMPARATOR
Intervention: Unmodified reference houses
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Two-storey prototype houses
Number of subjects: 6
Study: 26012697

Group type: EXPERIMENTAL
Intervention: Model group (n = 16)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Validation group (n = 10)
Number of subjects: 26
Study: 25456367

Group type: EXPERIMENTAL
Intervention: Capecitabine with or without oxaliplatin
Number of subjects: 8734

Group type: COMPARATOR
Intervention: XELOX or FOLFOX
Number of subjects: 8734

Group type: COMPARATOR
Intervention: Capecitabine-based regimens
Number of subjects: 8734
Study: 22965961

Group type: EXPERIMENTAL
Intervention: mFOLFOX6/cediranib 20 mg
Number of subjects: 1422

Group type: COMPARATOR
Intervention: mFOLFOX6/bevacizumab
Number of subjects: 1422
Study: 19944872

Group type: EXPERIMENTAL
Intervention: Usual care plus two massages (n=126)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Usual postoperative care (n=126)
Number of subjects: 252
Study: 17325505

Group type: EXPERIMENTAL
Intervention: Remifentanil (0-15 ng/ml) and inhaled sevoflurane (0-6 vol%)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sevoflurane-remifentanil anesthetics
Number of subjects: 24
Study: 15044672

Group type: EXPERIMENTAL
Intervention: Portion-controlled group (n = 26)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self-selected diet group (n = 27)
Number of subjects: 60
Study: 11472709

Group type: EXPERIMENTAL
Intervention: Vitamin E (1,200 IU at -13 hours)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: L-methionine (100 mg/kg at -6 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 10
Study: 9787721

Group type: EXPERIMENTAL
Intervention: Medication + diet
Number of subjects: 25

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 25
Study: 7664725

Group type: EXPERIMENTAL
Intervention: High dose of aqueous retinyl palmitate oral solution
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Comparison of average levels of vitamin A on day 7
Number of subjects: 34
Study: 2710815

Group type: EXPERIMENTAL
Intervention: Helium-neon laser irradiation (3 applications of 20 seconds each)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo 'stimulation'
Number of subjects: 24
Study: 773392

Group type: EXPERIMENTAL
Intervention: Quinidine polygalacturonate (short-acting), 4 daily doses
Number of subjects: 40

Group type: COMPARATOR
Intervention: Quinidine arabogalactan sulphate (long-acting), 2 daily doses
Number of subjects: 40
Study: 30720333

Group type: EXPERIMENTAL
Intervention: Feeding at 32-34°C (group 2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Feeding at 22-24°C (group 1)
Number of subjects: 80
Study: 27992698

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 25987659

Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 488

Group type: COMPARATOR
Intervention: Conventional Care Regimens (CCR)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Azacitidine (censored analysis)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Conventional Care Regimens (CCR) (censored analysis)
Number of subjects: 488
Study: 23993326

Group type: EXPERIMENTAL
Intervention: CABG surgery
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study: 21895859

Group type: EXPERIMENTAL
Intervention: Paroxetine controlled-release (CR)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Paroxetine immediate-release (IR)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 19262421

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (SIM)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard mannequin (MAN)
Number of subjects: 51
Study: 17895776

Group type: EXPERIMENTAL
Intervention: Right-arm injection of contrast material (80 mL, iodine concentration 300 mg/mL, 2 mL/s injection rate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Left-arm injection of contrast material (80 mL, iodine concentration 300 mg/mL, 2 mL/s injection rate)
Number of subjects: 60
Study: 14996362

Group type: EXPERIMENTAL
Intervention: Mosbar soap containing 20% DEET and 0.5% permethrin
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 127
Study: 11525314

Group type: EXPERIMENTAL
Intervention: Ro70-0004 (5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sildenafil (50 mg)
Number of subjects: 24
Study: 9794849

Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standard surgery
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conservative management
Number of subjects: 20
Study: 9350563

Group type: EXPERIMENTAL
Intervention: Triclosan-containing gel/dentifrice combination
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control gel/dentifrice combination
Number of subjects: 16
Study: 1778859

Group type: EXPERIMENTAL
Intervention: Cefpirome 1 or 2 g bd for 5-9 days
Number of subjects: 30
Study: 7340890

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg once daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg once daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Atenolol 200 mg once daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg once daily
Number of subjects: 13
Study: 30464005

Group type: EXPERIMENTAL
Intervention: Automated control (IntellO2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manual control
Number of subjects: 30
Study: 29288184

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment (pressure bandages, (bed) rest and wound care)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Surgical treatment (debridement, antibiotics and implant retention (DAIR))
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment followed by DAIR if persistent leakage at day 16-17
Number of subjects: 388
Study: 25819697

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Control
Number of subjects: 298
Study: 24792311

Group type: EXPERIMENTAL
Intervention: Bupivacaine block (0.25%) injected into trocar incision sites, 10 mL for incisions 8 mm or greater, 5 mL for incisions 5 mm or less.
Number of subjects: 135

Group type: COMPARATOR
Intervention: No bupivacaine block (control group).
Number of subjects: 135
Study: 20931252

Group type: EXPERIMENTAL
Intervention: Permaquick applied with the stiff micro‐hybrid composite Amelogen Hybrid (PMQ‐H, Ultradent)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Permaquick applied with the more flexible micro‐filled Amelogen Microfill (PMQ‐M, Ultradent)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Optibond FL applied with the micro‐hybrid composite Prodigy (OFL‐P, Kerr)
Number of subjects: 71
Study: 21124000

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) initiated within 6-24 hours, maintained for 48 hours at 32-33°C, followed by slow rewarming.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normothermia (control group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Patients aged <4 years
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nonaccidental TBI
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Global injury on CT
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Initial GCS and GOS scores
Number of subjects: 47
Study: 18357403

Group type: EXPERIMENTAL
Intervention: Action Schools! BC (AS! BC) program
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 410